ARS Pharmaceuticals Balance Sheet (2020-2026)

Reported Financials

ARS Pharmaceuticals Quarterly Balance Sheet

Periods 26 quarters

Latest Jun 2026

ARS Pharmaceuticals reported total assets of $249.50M and total liabilities of $236.98M for the quarter ended Jun 2026, down 20.4% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	300.66M	60.06M	233.99M	218.69M	203.22M	210.52M	87.86M	119.02M	60.53M	70.97M	56.01M	36.63M	39.66M	50.82M	39.86M	51.54M	59.56M	41.32M	24.32M	8.16M
Short-term InvestmentsInvestments (Current)			19.86M	39.28M	63.40M	63.86M	176.69M	133.19M	181.37M	157.39M	167.63M	182.12M	164.97M	263.20M	235.86M	188.59M	228.65M	203.67M	176.65M	135.68M
Cash & Current Investments	300.66M	60.06M	253.85M	257.98M	266.62M	262.30M	264.50M	252.20M	241.90M	228.40M	223.60M	218.70M	204.60M	314.00M	275.70M	240.10M	288.20M	245.00M	201.00M	143.80M
Receivables - NetNet Receivables													0.77M	8.18M	9.30M	25.13M	36.45M	25.35M	28.66M	46.84M
Receivables - OtherOther Receivables		0.16M				0.21M	0.31M	0.35M	0.21M	0.65M	0.28M	0.12M	0.13M	1.23M	0.96M	2.03M	4.27M
Receivables										0.65M			0.91M	9.41M	10.27M	27.15M	40.72M	25.35M	28.66M	46.84M
Raw Materials													0.42M
Work In Process													0.29M
Finished Goods														5.21M	7.27M
Inventory													0.71M	5.21M	7.27M	8.74M	7.78M	8.37M	8.82M	11.69M
Prepaid Assets	4.70M	0.67M	7.49M	5.15M	4.17M	3.32M	2.80M	2.83M	2.56M	3.37M	2.61M	1.99M	2.68M	6.89M	11.56M	7.44M	6.42M	6.19M	6.79M	9.14M
Current Assets	305.36M	60.73M	261.33M	263.13M	270.80M	277.70M	267.35M	255.03M	244.47M	231.73M	226.24M	220.74M	208.79M	334.30M	303.86M	281.44M	338.86M	284.90M	245.24M	211.51M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	1.91M	0.07M	2.43M	2.48M	0.01M	0.33M	0.58M	0.59M	0.62M	0.57M	0.62M	0.64M	0.84M	1.07M	1.07M	1.07M	1.21M	2.46M	2.29M	2.08M
Long-Term Investments	39.94M	64.78M	43.97M	24.22M
Intangibles													7.50M	7.37M	7.24M	12.97M	14.73M	14.45M	14.18M	13.90M
Goodwill & Intangibles														7.37M	7.24M	12.97M	14.73M	14.45M	14.18M	13.90M
Other Non-Current Assets	0.35M	0.02M	0.25M	0.25M	2.40M	2.96M	2.86M	2.77M	3.17M	0.64M	0.53M	0.45M	0.38M	3.11M	3.13M	3.05M	2.92M	2.79M	2.65M	2.96M
Non-Current Assets	47.21M	0.72M	51.14M	30.87M	0.27M	3.73M	3.84M	3.72M	4.09M	1.46M	1.34M	1.23M	8.81M	16.86M	23.46M	32.04M	33.94M	42.76M	42.34M	37.98M
Assets	352.56M	61.45M	312.47M	294.00M	271.06M	281.44M	271.19M	258.75M	248.56M	233.19M	227.58M	221.97M	217.60M	351.15M	327.32M	313.47M	372.80M	327.65M	287.57M	249.50M
Liabilities
Current Liabilities
Accounts Payables	1.72M	3.11M	2.63M	2.11M	0.13M	4.93M	9.60M	9.82M	10.95M	2.15M	3.50M	6.57M	16.52M	22.84M	27.01M	44.26M	49.77M	37.95M	48.26M	59.73M
Notes Payables		3.48M
Payables	1.72M	6.59M	2.63M	2.11M	0.13M	4.93M	9.60M	9.82M	10.95M	2.15M	3.50M	6.57M	16.52M	22.84M	27.01M	44.26M	49.77M	37.95M	48.26M	59.73M
Accumulated Expenses	12.54M	11.73M	0.40M	0.60M	3.65M	12.00M
Other Accumulated Expenses														4.07M			11.27M	6.88M	20.41M	13.48M
Short term Debt
Current Deferred Revenue		1.46M				0.28M	0.01M							0.56M	0.54M	0.75M	0.53M	0.61M	0.76M	0.54M
Total Current Liabilities	15.35M	8.19M	14.81M	11.14M	3.99M	5.44M	9.84M	10.05M	11.18M	2.39M	3.71M	6.72M	16.62M	23.44M	27.62M	45.60M	50.88M	39.15M	49.61M	60.86M
Non-Current Liabilities
Non-Current Debt		4.93M												69.38M	69.38M	71.96M	72.04M	72.14M	74.67M	74.93M
Non-Current Deffered Revenue		3.00M				2.85M								1.53M	1.34M	1.10M	1.27M	1.13M	0.98M	1.11M
Preferred Stock Liabilities		76.04M
Operating Leases	5.08M	0.48M	4.43M	4.07M		0.25M	0.20M	0.15M	0.09M	0.04M						1.07M	0.95M
Other Non-Current Liabilities		0.08M														1.42M	3.78M	4.61M	4.48M	3.40M
Total Non-Current Liabilities		92.63M				8.55M								94.36M		119.73M	221.37M	208.79M	221.78M	233.58M
Total Liabilities	20.43M	92.72M	350.72M	338.03M	321.22M	8.55M	10.04M	10.20M	11.27M	2.43M	3.71M	6.72M	16.62M	94.36M	98.34M	121.15M	225.15M	213.39M	226.26M	236.98M
Shareholder's Equity
Total Debt		8.41M												69.38M	69.38M	71.96M	72.04M	72.14M	74.67M	74.93M
Common Equity	332.13M	-31.27M	-38.26M	-44.03M	-50.16M	272.89M	261.15M	248.55M	237.28M	230.76M	223.87M	215.24M	200.98M	256.80M	228.97M	192.32M	147.66M	114.26M	61.31M	12.51M
Liabilities and Shareholders Equity	352.56M	61.45M	312.47M	294.00M	271.06M	281.44M	271.19M	258.75M	248.56M	233.19M	227.58M	221.97M	217.60M	351.15M	327.32M	313.47M	372.80M	327.65M	287.57M	249.50M
Retained Earnings	-162.80M	-42.26M	-210.84M	-230.27M	-248.14M	-76.94M	-91.90M	-109.27M	-124.14M	-131.30M	-141.59M	-154.11M	-173.24M	-123.31M	-157.25M	-202.13M	-253.28M	-294.60M	-355.22M	-417.56M

ARS Pharmaceuticals Balance Sheet API

Pull ARS Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SPRY&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "SPRY", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=SPRY&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

ARS Pharmaceuticals SPRY Balance Sheet (2020-2026)

ARS Pharmaceuticals Quarterly Balance Sheet

ARS Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password